Marla C. Dubinsky, MD

Susan and Leonard Feinstein IBD Center, Icahn School of Medicine, Mount Sinai

Poster(s):

• C0361 - Association of Ulcerative Colitis Bowel Urgency Improvement with Clinical Response and Remission
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET

• C0362 - Major Cardiovascular Adverse Events by Baseline Cardiovascular Risk Stratification in Patients With Ulcerative Colitis Treated With Tofacitinib: Data From the OCTAVE Clinical Program
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET

• C0363 - The Impact of Bowel Urgency on the Lives of Patients With Ulcerative Colitis in the U.S. and Europe: Communicating Needs and Features of IBD Experiences (CONFIDE) Survey
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET

• C0364 - Assessment of Health-Related Quality of Life and Patient-Reported Outcomes With Tofacitinib Treatment Stratified by Age in Patients From the OCTAVE Ulcerative Colitis Clinical Program
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET

• C0365 - Symptoms and Laboratory Values as Proxies for Endoscopic and Histologic Clinical Endpoints in Ulcerative Colitis: A Mediation Analysis Based on Upadacitinib Phase 3 Induction Trials
  Monday, October 24, 2022

  3:00 PM – 5:00 PM ET